Published in Cancer Weekly, February 2nd, 2010
"The aim of the study was to explore the immunological mechanism of anaphylaxis to PBV. PBV allergen threshold basophil sensitivity, CD-sens, was performed on cells from nine patients diagnosed as having had adverse reactions to PBV. The mechanisms of the CD-sens were studied by immunological and immuno-chemical methods. Five of the nine patients had a positive CD-sens to PBV which was completely eliminated by washing the cells in phosphate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.